Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
Infections caused by the opportunistic pathogen Pseudomonas aeruginosa can be difficult to treat due to innate and acquired antibiotic resistance and this is exacerbated by the emergence of multi-drug resistant strains. Unfortunately, no licensed vaccine yet exists to prevent Pseudomonas infections....
Main Authors: | Sayan Das, Debaki R. Howlader, Qi Zheng, Siva Sai Kumar Ratnakaram, Sean K. Whittier, Ti Lu, Johnathan D. Keith, William D. Picking, Susan E. Birket, Wendy L. Picking |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.583008/full |
Similar Items
-
Effect of Two Unique Nanoparticle Formulations on the Efficacy of a Broadly Protective Vaccine Against Pseudomonas Aeruginosa
by: Debaki R. Howlader, et al.
Published: (2021-08-01) -
Development of a nano-emulsion based multivalent protein subunit vaccine against Pseudomonas aeruginosa
by: Debaki R. Howlader, et al.
Published: (2024-04-01) -
The <i>Shigella</i> Type III Secretion System: An Overview from Top to Bottom
by: Meenakumari Muthuramalingam, et al.
Published: (2021-02-01) -
Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
by: Ti Lu, et al.
Published: (2023-09-01) -
The L-DBF vaccine cross protects mice against different Shigella serotypes after prior exposure to the pathogen
by: Ti Lu, et al.
Published: (2023-12-01)